NT-proBNP The Gold Standard Biomarker in Heart Failure

被引：76
|
作者：
Mckie, Paul M. [1 ]
Burnett, John C., Jr. [1 ]
机构：
[1] Mayo Clin & Mayo Fdn, Cardiorenal Res Lab, Dept Cardiovasc Dis, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 22期
关键词：
biomarker; chronic heart failure; natriuretic peptide; reduced ejection fraction; NATRIURETIC-PEPTIDE; NEPRILYSIN INHIBITION; CARDIOVASCULAR EVENTS; GENERAL COMMUNITY; ATRIAL; ENALAPRIL;
D O I：
10.1016/j.jacc.2016.10.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2437 / 2439
页数：3
相关论文
共 50 条
  • [1] NT-proBNP as a neuroendocrine tumor biomarker: beyond heart failure
    Komarnicki, Pawel
    Gut, Pawel
    Musialkiewicz, Jan
    Cieslewicz, Maja
    Maciejewski, Adam
    Patel, Prachi
    Mastorakos, George
    Ruchala, Marek
    ENDOCRINE CONNECTIONS, 2023, 12 (10)
  • [2] Usefulness of NT-ProBNP as a biomarker of clinical status in outpatients with chronic heart failure
    Casado, Jesus M.
    Diza, Ana
    Suarez, Carmen
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (02): : 206 - 210
  • [3] NT-proBNP: An independent predictor of heart failure
    Bibbins-Domingo, K
    Ali, S
    Wu, AH
    Whooley, MA
    CIRCULATION, 2006, 113 (08) : E333 - E333
  • [4] Sequential Evaluation of NT-proBNP in Heart Failure
    Armstrong, Paul W.
    Zheng, Yinggan
    Troughton, Richard W.
    Lund, Lars H.
    Zhang, Jian
    Lam, Carolyn S. P.
    Westerhout, Cynthia M.
    Blaustein, Robert O.
    Butler, Javed
    Hernandez, Adrian F.
    Roessig, Lothar
    O'Connor, Christopher M.
    Voors, Adrian A.
    Ezekowitz, Justin A.
    JACC-HEART FAILURE, 2022, 10 (09) : 677 - 688
  • [5] NT-PROBNP GUIDED HEART FAILURE THERAPY
    Januzzi, James L., Jr.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S174 - S174
  • [6] NT-proBNP as a biomarker for the development of carcinoid heart disease
    Bhattacharyya, S.
    Toumpanakis, C.
    Caplin, M.
    Davar, J.
    EUROPEAN HEART JOURNAL, 2007, 28 : 656 - 656
  • [7] NT-proBNP as a biomarker for the development of carcinoid heart disease
    Bhattacharyya, S.
    Toumpanakis, C.
    Caplin, M.
    Davar, J.
    HEART, 2007, 93 : A78 - A78
  • [8] NT-proBNP, to be or not to be a BPD biomarker?
    Danhaive, Olivier
    Hocq, Catheline
    PEDIATRIC RESEARCH, 2024,
  • [9] Is ADMA a better biomarker for heart failure in adults with congenital heart disease than NT-proBNP?
    Tutarel, O.
    Denecke, A.
    Bode-Boeger, S.
    Martens-Lobenhoffer, J.
    Eden, G.
    Schieffer, B.
    Bauersachs, J.
    Kielstein, J. T.
    Westhoff-Bleck, M.
    EUROPEAN HEART JOURNAL, 2011, 32 : 121 - 121
  • [10] Predictors of NT-proBNP response in primary care patients with heart failure and NT-proBNP guided therapy
    Erntell, H.
    Swedberg, K.
    Jorgensen, L.
    Dahlstrom, U.
    Persson, H.
    EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S31 - S31
12345